Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Savitri Krishnamurthy
Observed names:
Krishnamurthy S,
S Krishnamurthy,
SA Krishnamurthy
Institution:
The University of Texas MD Anderson Cancer Center
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Baylor College of Medicine,
Dan L Duncan Comprehensive Cancer Center
ORCID:
0000-0001-9030-4136
Observed ORCID:
0000-0001-9030-4136
OpenAlex ID:
A5085679549
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma
2026
·
Dennis Wylie
, Xiaoping Wang
, et al.
·
Science Advances
·
9
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
2026
·
Eleonora Nicolò
, François Bertucci
, et al.
·
Cancer
·
4
Abstract OT1-02-01: A phase II study of anti-PD-1 (MK-3475) therapy in patients with metastatic inflammatory breast cancer (MIBC) or non-IBC triple negative breast cancer (non-IBC TNBC) who have achieved clinical response or stable disease to prior chemotherapy
2018
·
JS Willey
, CA Parker
, et al.
·
Cancer Research
·
3
Examining the tumor microbiology and microenvironment of patients with triple-negative inflammatory breast cancer receiving KEYNOTE-522.
2026
·
Azadeh Nasrazadani
, Bora Lim
, et al.
·
Journal of Clinical Oncology
·
1
Epidemiological Risk Factors Associated with Inflammatory Breast Cancer Triple Negative Subtype
2012
·
Atkinson RL
, Sexton K
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
1
Identifying patients with human epidermal growth factor receptor 2 (HER2)–low and –ultralow breast cancer (BC): Use of digital, artificial intelligence (AI)–based computational algorithms to assist HER2 scoring by pathologists.
2026
·
Savitri Krishnamurthy
, Thaer Khoury
, et al.
·
Journal of Clinical Oncology
Cross-modality AI modeling of histopathology images to stratify outcomes among patients treated with hormonal or chemo-hormonal therapy in ER+/HER2− breast cancer.
2026
·
Hassan Muhammad
, Shweta S. Chavan
, et al.
·
Journal of Clinical Oncology
Abstract LB280: PDIA4-NF-κB signaling mediates soluble E-cadherin-driven inflammatory breast cancer progression
2026
·
Xiaoding Hu
, Kiros Haddish Tesfamariam
, et al.
·
Cancer Research
Abstract P5-01-02: Quantitative assessment of tumor response to neoadjuvant chemotherapy in women with locoregional invasive breast cancer using Tc99m sestamibi molecular breast imaging - preliminary results
2018
·
GM Rauch
, BE Adrada
, et al.
·
Cancer Research
Abstract OT1-01-05: A phase II study using talimogene laherparepvec as a single agent for inflammatory breast cancer or non-inflammatory breast cancer patients with inoperable local recurrence
2018
·
JS Willey
, AN Marx
, et al.
·
Cancer Research
Abstract P3-10-01: Epidemiological risk factors and normal breast tissue markers in inflammatory breast cancer
2012
·
RL Atkinson
, KR Sexton
, et al.
·
Cancer Research
Correlation between response to neoadjuvant chemotherapy (NACT) with single agent taxanes and HER-2 gene amplification in patients with breast carcinoma
2004
·
A.M Gonzalez-Angulo
, S Krishnamurthy
, et al.
·
European Journal of Cancer Supplements
Show more works
View as search
Works count:
12
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type